| Document Date: 2003-06-28 16:27:38
Open Document File Size: 533,59 KBShare Result on Facebook
City Houston / Huntington Beach / / Company Fruehauf / NuOncolology Labs / Peter Nygren MD PhD Weisenthal Cancer Group / / Continent Asia / Europe / / Country United States / / / Facility Uppsala University / / IndustryTerm laboratory technology / culture media / oncogene products / / MedicalCondition human hematologic neoplasms / tumor / neoplasms / tumors showing / ovarian cancer / non-Hodgkin's lymphoma / cancer / hematologic neoplasm / tumors / disease / neoplasm / non-stomach GI adenocarcinomas / acute leukemia / GI neoplasms / given rare tumor / stomach and colorectal cancer / lymphatic neoplasm / solid tumors / colon cancers / testicular cancer / esthesioneuroblastoma / human lymphatic neoplasms / given tumor / human tumors / primary peritoneal carcinoma / acute lymphoblastic leukemia / human neoplasms / acute non-lymphocytic leukemia / true tumor / high response rate neoplasms / lymphatic neoplasms / injury / low response rate tumors / diseases / hematologic neoplasms / infection / head and neck cancer / ANLL / cholangiocarcinoma / breast cancer / pancreatic cancer / / MedicalTreatment intraperitoneal chemotherapy / antibiotics / chemotherapy / radiation / / Organization Association of Tennis Professionals / Advocates of CCDRT / MTT / FDA / Uppsala University / ATP / / Person Note / / / Position investigator / physician / / Product cisplatin / etoposide / paclitaxel / / ProvinceOrState California / / SportsEvent NHL / / Technology laboratory technology / pharmacokinetics / radiation / DNA synthesis / chemotherapy / apoptosis / /
SocialTag |
Current Status of Cell Culture Drug Resistance Testing 1 2